Search research articles
Contact Us
Filters
Showing results (271-280 of 703) with videos related to
Page
of 71
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
M H Pollack, A Betof, H Dearden, et al.
The American Journal of Surgical Pathology
|
April 19, 2022
Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi
Andrew J Colebatch, Chandra Adhikari, Russell J Diefenbach, et al.
The Lancet. Oncology
|
April 1, 2018
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V Long, Victoria Atkinson, Serigne Lo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 11, 2021
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location
Siujoon Choi, Angela Hong, Tim Wang, et al.
Internal Medicine Journal
|
September 26, 2025
Structured curriculum vitae scoring: a possible means to improve female representation in specialty selection?
Brittany Suann, Christina Gao, Thomas Muecke, et al.
British Journal of Cancer
|
February 14, 2013
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
J S Wilmott, A M Menzies, L E Haydu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 18, 2014
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
Cecilia Lezcano, Chung-Wei Lee, Allison R Larson, et al.
The Journal of Investigative Dermatology
|
February 3, 2023
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics
Zizhen Ming, Su Yin Lim, Ashleigh Stewart, et al.
Biomarker Research
|
May 16, 2017
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered <i>BRAF</i> transcript splicing
Gulietta M Pupo, Suzanah C Boyd, Carina Fung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets
Ismael A Vergara, Karina Aivazian, Matteo S Carlino, et al.
Page
of 71
Search research articles
Search
Showing results (271-280 of 703) with videos related to
Sort By:
Page
of 71
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2017
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma
M H Pollack, A Betof, H Dearden, et al.
The American Journal of Surgical Pathology
|
April 19, 2022
Comprehensive Clinical, Histopathologic, and Molecular Analysis and Long-term Follow-up of Patients With Nodal Blue Nevi
Andrew J Colebatch, Chandra Adhikari, Russell J Diefenbach, et al.
The Lancet. Oncology
|
April 1, 2018
Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study
Georgina V Long, Victoria Atkinson, Serigne Lo, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
June 11, 2021
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location
Siujoon Choi, Angela Hong, Tim Wang, et al.
Internal Medicine Journal
|
September 26, 2025
Structured curriculum vitae scoring: a possible means to improve female representation in specialty selection?
Brittany Suann, Christina Gao, Thomas Muecke, et al.
British Journal of Cancer
|
February 14, 2013
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
J S Wilmott, A M Menzies, L E Haydu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 18, 2014
Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
Cecilia Lezcano, Chung-Wei Lee, Allison R Larson, et al.
The Journal of Investigative Dermatology
|
February 3, 2023
IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics
Zizhen Ming, Su Yin Lim, Ashleigh Stewart, et al.
Biomarker Research
|
May 16, 2017
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered <i>BRAF</i> transcript splicing
Gulietta M Pupo, Suzanah C Boyd, Carina Fung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 14, 2023
Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets
Ismael A Vergara, Karina Aivazian, Matteo S Carlino, et al.
Page
of 71